pBabe neo human Frataxin
(Plasmid
#11503)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 11503 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBABE neo
-
Backbone manufacturerpBABE-neo is available at Addgene
- Backbone size w/o insert (bp) 5330
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFrataxin
-
Alt nameFRDA
-
SpeciesH. sapiens (human)
-
Insert Size (bp)650
-
Entrez GeneFXN (a.k.a. CyaY, FA, FARR, FRDA, X25)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer pBABE 5 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This plasmid was cloned before there was any consensus sequence for frataxin. There are 2 mutations with the currently available frataxin sequence - L140P R165C. The effect of these mutations is unknown.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBabe neo human Frataxin was a gift from Ronald Kahn (Addgene plasmid # 11503 ; http://n2t.net/addgene:11503 ; RRID:Addgene_11503) -
For your References section:
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Ristow M, Pfister MF, Yee AJ, Schubert M, Michael L, Zhang CY, Ueki K, Michael MD, Lowell BB, Kahn CR. Proc Natl Acad Sci U S A. 2000 Oct 24. 97(22):12239-43. 10.1073/pnas.220403797 PubMed 11035806